Location History:
- Takoma Park, MD (US) (2010)
- Rockville, MD (US) (2012 - 2020)
Company Filing History:
4 out of 3,540 
3 out of 937 
3 out of 975 
Years Active: 2010-2020
Title: Innovator Spotlight: George Wright - Pioneering Advances in Lymphoma Research
Introduction:
George Wright, a prolific inventor based in Rockville, MD (US), has made significant contributions to the field of lymphoma research with a total of 4 patents to his name. Among these patents, his latest innovations focus on methods for identifying, diagnosing, and predicting survival of lymphomas based on gene expression data, showcasing his dedication to advancing precision medicine in the treatment of lymphoproliferative disorders.
Latest Patents:
Wright's groundbreaking work includes the development of the Lymph Dx microarray, a novel tool designed to extract gene expression data from lymphoma samples. This microarray, coupled with innovative methods for analyzing lymphoma gene expressions, not only aids in identifying specific types of lymphomas but also enables the prediction of survival outcomes for individuals diagnosed with these disorders. His patent on a survival predictor for diffuse large B cell lymphoma (DLBCL) further underscores his commitment to improving patient outcomes through gene expression-based approaches.
Career Highlights:
Throughout his career, George Wright has collaborated with esteemed institutions such as the United States of America, represented by the Secretary of the Department of Health and Human Services, and the University of Nebraska. His involvement in pioneering research projects underscores his reputation as a forward-thinking inventor dedicated to pushing the boundaries of medical science.
Collaborations:
Wright has had the privilege of working alongside accomplished colleagues in the field of lymphoma research, including Bruce Tan and Wyndham H Wilson. Together, they have leveraged their collective expertise to drive advancements in survival prediction models for lymphoma patients, contributing significantly to the development of personalized treatment strategies in oncology.
Conclusion:
George Wright's innovative contributions to lymphoma research, as evidenced by his trailblazing patents and collaborative efforts with leading institutions and researchers, highlight his unwavering commitment to revolutionizing the landscape of precision medicine. His work not only has the potential to transform how lymphomas are diagnosed and treated but also to improve survival outcomes for individuals affected by these challenging disorders.